Psychedelic News of the Week
Britons seek psychedelic therapy abroad, an MDMA memoir heads to court, a key psychedelic questionnaire is questioned, and Compass maps its psilocybin launch.
What’s New in
Psychedelics — and Why
It Matters
Your source for psychedelic news, scientific breakthroughs, legal updates, and expert insights.
Weekly Digest
MindShift 101:Our curated digest,
every Friday in your inbox
The most important conversations shaping the future of psychedelics, delivered weekly.
Joined by 12,000+ readers
Latest
Insights
Can Psilocybin Change How We Treat Anorexia?
Standard treatment fails up to 30% of people with anorexia. The team behind Imperial College’s psilocybin pilot shares what changed for participants and how much research is still…
Insights
Music is The Bridge: MAPS Launches Psychedelic Education Initiative
The Music is the Bridge series explores music and storytelling to introduce new audiences to evidence-based education and reduce stigma.
News
487 Records, 27 Countries. What PsyAccess Reveals About Psychedelic Care in Europe
PsyAccess maps 480+ records across Europe, from licensed ketamine clinics to clinical trial sites. Experts and practitioners explain why it matters.
News
The FDA Just Held Its First Hearing on Psychedelic Medicine
Four hours at the FDA made it official: approving a psychedelic is the easy part. Everything that matters comes after.
Science
Can Psychedelic-Assisted Therapy Help With Severe Anxiety?
Which psychedelics actually have evidence for anxiety? We break it down with Floris Wolswijk, founder of research database Blossom.
Insights
EMDR Therapy in the UK, and How It Compares with Psychedelic Therapy
A clear look at EMDR in the UK: how it actually works, what it costs, how to find someone properly accredited, and how it compares with MDMA, psilocybin…
Insights
Can Non-Hallucinogenic Psychoplastogens Deliver the Therapeutic Signal?
Neuroplastogens promise psychedelics' brain-rewiring effects without the trip. But can plasticity alone deliver the therapeutic signal?
Science
Could Psychedelics Support Healthy Aging and Longevity?
Research into psychedelics for healthy aging is now being backed by millions of pounds.
News
Locked in Schedule 1. UK and the Psilocybin Question
A recent nationwide poll finds broad support for psilocybin-assisted therapy in the UK. But does reality match public opinion?
Loading more stories...
Ready when you are
Free, private, and takes less than a minute.
